Status:
UNKNOWN
Guided ACT and for Adults With ASD
Lead Sponsor:
University of Lincoln
Collaborating Sponsors:
Nottinghamshire Healthcare NHS Trust
Conditions:
Autism Spectrum Disorder (ASD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate the efficacy of guided self-help Acceptance Commitment Therapy (ACT) for adults who have a diagnosis for Autistic Spectrum Disorder (ASD) and are experiencing psychologi...
Detailed Description
INTRODUCTION High levels of psychiatric co-morbidity have been found with adults who receive a diagnosis of Autistic Spectrum Disorder (ASD); including stress, anxiety, depression and OCD. Acceptance...
Eligibility Criteria
Inclusion
- 18+ years old with a formal diagnosis of Autistic Spectrum Disorder, without a diagnosis if an Intellectual Disability.
- To be over the age of 18 years.
- Accessing Nottingham City Autism Service
- Experiencing elevated anxiety, and / or stress, and /or depression and meet the clinical threshold or moderate on the Depression, Anxiety and Stress Scale.
- Access to the internet via an electronic device (to complete electronic measures).
- Agreement and knowledge of the time commitment for the completion of the intervention, competition of measure and change questionnaire at the end of the study.
Exclusion
- Unable to communicate fluently in English (justification: the cost of hiring an interpreter).
- Unable to read English (justification: participant will be unable to read and engage in the bibliotherapy)
- Adults who are currently accessing psychological therapy. If participants start psychological therapy during the study, they will be removed from the study (justification: unable to separate out effects of research intervention from psychological therapy intervention).
- If they have a co-morbid diagnosis of intellectual disability (justification: may have different needs regarding therapy adaptations.
- No access to mobile or internet (justification: unable to complete measures).
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04376151
Start Date
September 1 2020
End Date
August 20 2022
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nottingham City Autisum Service
Nottingham, Nottinghamshire, United Kingdom, NG6 9DR